Cargando…

LncRNA Taurine Upregulated Gene 1 as a Potential Biomarker in the Clinicopathology and Prognosis of Multiple Malignant Tumors: A Meta-Analysis

BACKGROUND: The lncRNA taurine upregulated gene 1 (TUG1) is a recently identified potential biomarker in cancer. However, its prognostic role in various cancers is inconsistent among published data. We conducted this meta-analysis to comprehensively confirm the prognostic effect of TUG1 in malignant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Qi, Wu, Jingjing, Wang, Hui, Li, Na, Yang, Zhen, Zhang, Mingjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943310/ https://www.ncbi.nlm.nih.gov/pubmed/33747256 http://dx.doi.org/10.1155/2021/8818363

Ejemplares similares

The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer
por: Azizidoost, Shirin, et al.
Publicado: (2022)

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis
por: Tian, Shubo, et al.
Publicado: (2020)

LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells
por: Zhao, Xiao-bo, et al.
Publicado: (2016)

LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis
por: Li, Duo, et al.
Publicado: (2022)

Overexpression of LncRNA SNHG14 as a biomarker of clinicopathological and prognosis value in human cancers: A meta-analysis and bioinformatics analysis
por: Liu, Bin, et al.
Publicado: (2022)

Upregulation of lncRNA SNHG1 is associated with metastasis and poor prognosis in cancers: A meta-analysis
por: Yu, Jing, et al.
Publicado: (2019)

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics
por: Yu, Lingling, et al.
Publicado: (2018)

Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
por: Dong, Hang, et al.
Publicado: (2019)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis of cholangiocarcinoma: a systematic review and meta-analysis
por: Dai, Kangfu, et al.
Publicado: (2019)

lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1
por: Hu, Yu, et al.
Publicado: (2020)

Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
por: Shen, Xiaogang, et al.
Publicado: (2017)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

Prognostic and Clinicopathological Significance of lncRNA MVIH in Cancer Patients
por: Zhang, Yi, et al.
Publicado: (2019)

LncRNA SNHG6 role in clinicopathological parameters in cancers
por: Khan, Khushbukhat, et al.
Publicado: (2023)

Signaling Pathway of Taurine-Induced Upregulation of TXNIP
por: Satsu, Hideo, et al.
Publicado: (2022)

Upregulation of BCAM and its sense lncRNA BAN are associated with gastric cancer metastasis and poor prognosis
por: Jin, Juan, et al.
Publicado: (2020)

The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis
por: Tian, Tian, et al.
Publicado: (2018)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

Role of long noncoding RNA taurine‐upregulated gene 1 in cancers
por: Da, Miao, et al.
Publicado: (2021)

LINK-A lncRNA is upregulated in metastatic non-small cell lung cancer and is associated with poor prognosis
por: Liu, Junqiang, et al.
Publicado: (2019)

LncRNA HEIH expression in cancer prognosis: A review and meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2023)

lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Chao, Yanjun, et al.
Publicado: (2019)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function
por: Mi, Zhanhu, et al.
Publicado: (2021)

LncRNA LINC02257: A Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer
por: Chen, Mei, et al.
Publicado: (2022)

Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
por: Gao, Yue, et al.
Publicado: (2023)

lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer
por: Chen, Cheng, et al.
Publicado: (2020)

Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer
por: Ding, Xian-zhen, et al.
Publicado: (2021)

Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression
por: Guo, Qiuyan, et al.
Publicado: (2015)

Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)
por: Baliou, Stella, et al.
Publicado: (2020)

Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer
por: Li, Bin, et al.
Publicado: (2020)

LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
por: Yun-Bo, Feng, et al.
Publicado: (2016)

LncRNA NKILA was upregulated in diabetic cardiomyopathy with early prediction values
por: Li, Qingyong, et al.
Publicado: (2019)

LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020)

lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis
por: Chen, Xiaoliang, et al.
Publicado: (2018)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis
por: Wang, Xuhua, et al.
Publicado: (2022)

15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma
por: Zhang, Qiong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5in6busso0u02o9v39fndmtjnm